Literature DB >> 12013170

Medical management of early fetal demise using sublingual misoprostol.

Prabhath T Wagaarachchi1, Premila W Ashok, Norman C Smith, Allan Templeton.   

Abstract

The aim of this study was to determine the efficacy of mifepristone in combination with sublingual misoprostol for the medical management of early fetal demise. Fifty-six consecutive women were studied prospectively. The mean (SD) gestation at diagnosis was 9.6 weeks (1.84). Four women had complete miscarriage with mifepristone alone. The overall success rate was 83.9% and the median induction-miscarriage interval was 8.19 hours (range 0.83 to 37.50 hours). Of those women who had a successful outcome, 91.5% were satisfied with the regimen. Sublingual misoprostol in combination with mifepristone is an effective and safe alternative to vaginal or oral misoprostol in the management of early fetal demise.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12013170     DOI: 10.1111/j.1471-0528.2002.01075.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  2 in total

1.  Acceptability and safety profile of oral and sublingual misoprostol for uterine evacuation following early fetal demise.

Authors:  Devendra Singh Kushwah; Beenu Kushwah; Mohd Tariq Salman; V K Verma
Journal:  Indian J Pharmacol       Date:  2011-05       Impact factor: 1.200

2.  Expectant management of miscarriage in view of NICE Guideline 154.

Authors:  Junaid Rafi; Haroona Khalil
Journal:  J Pregnancy       Date:  2014-04-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.